Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Carlos Salama discusses how hospitalized patients with Covid-19 pneumonia who were not receiving mechanical ventilation and received tocilizumab showed a reduction in the likelihood of progression to the composite outcome of mechanical ventilation or death, but it did not improve survival.

Image courtesy of Carlos Salama

Image courtesy of interviewee

Leave a Reply

Your email address will not be published.

×
Guest visitors to the Faculti website can view any insight monthly. You have insight(s) remaining for this month or Register for free as an individual and view thousands of insights in our archive today or subscribe for subject access.

You may already have unlimited institutional access to Faculti. Many colleges and universities have institutional memberships. If you are affiliated with a subscribing institution, please access this site through your SSO/EZproxy/IP address. This should permit you with unlimited views. However, you will not be able to view non-subscribed to content.

Copyright © Faculti Media Limited 2022. All rights reserved.
error:

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×